MDR 기술 문서(부속서 II 및 III) 구조화 방법. 실무 규정 준수 가이드

REPHINE SPEECH MARKS OPEN MEDICALDEVICES

Is your organisation fully prepared to structure MDR Technical Documentation under Annex II and Annex III?
REPHINE SPEECH MARKS CLOSE MEDICALDEVICES

About this Whitepaper

This guide translates the legal language of Annex II and Annex III into a practical, reviewer friendly structure that supports faster assessment by Notified Bodies. It explains how to present device information, design and manufacturing evidence, GSPR demonstrations, verification and validation data, clinical evaluation and PMS outputs in a coherent and logically connected way.
 
The document emphasises the MDR requirement for Technical Documentation to be clear, organised, readily searchable and unambiguous. It also highlights the most frequent causes of review delays including incomplete submissions, inconsistent terminology and dossiers that require reviewers to search for links between claims and evidence.
Through best practice recommendations and explanations of common Notified Body observations, the white paper guides manufacturers to create documentation that supports lifecycle consistency and reduces question cycles.

What’s changing?

Organisations must adapt to MDR review patterns in which Notified Bodies do not read dossiers linearly. Instead, they move quickly between intended purpose, classification, GSPR mapping, risk management, verification and validation, clinical evidence and PMS. To meet expectations, manufacturers need Technical Documentation that demonstrates:

  • Clean device definition including intended purpose, variants, accessories and Basic UDI DI scope
  • Complete and cohesive information supplied with the device including labels, IFU and promotional materials
  • Clear design and manufacturing information with traceable links between design inputs, outputs, risk controls and verification evidence
  • Robust GSPR mapping with precise evidence references and justification for applicability or non applicability
  • Risk management aligned with ISO 14971 and integrated with verification, validation, clinical evaluation, usability and PMS
  • Verification and validation evidence that is complete, traceable and supported by accredited laboratories
  • PMS systems that operate as lifecycle feedback mechanisms and drive updates to risk, clinical evidence and documentation
  • SSCP requirements for implantable and class III devices where transparency and alignment with clinical and PMS outputs are essential
These elements reflect Notified Body expectations for documentation that is consistent, traceable and supported by justifiable regulatory reasoning.

Why it matters for your business

Well structured MDR Technical Documentation directly influences review timelines, inspection performance and market access. Poor organisation or inconsistent evidence presentation typically leads to additional reviewer rounds and delayed CE marking.
 
Manufacturers must therefore:
  • Map all device information and evidence to a coherent MDR aligned structure
  • Maintain terminology consistency across all documents including CER, RMF, IFU and PMS
  • Demonstrate clear requirement to evidence traceability with updated GSPR matrices and verification and validation summaries
  • Strengthen design and risk management integration through complete traceability between user needs, design inputs, hazards, risk controls and testing
  • Ensure PMS outputs genuinely inform lifecycle safety and performance decisions and align with clinical and risk files
A mature dossier signals system control, regulatory readiness and a high degree of organisational quality. It supports operational efficiency and positions the business for smoother regulatory pathways.

Take action now

With the MDR in full effect and Notified Bodies operating under heavy demand, documentation quality has never been more important. Organisations that invest early in structuring, updating and maintaining their Technical Documentation will minimise delays, reduce review friction and build a more resilient compliance framework.
 
This white paper provides practical recommendations, traceability models, architecture templates and insights into common review pitfalls, helping manufacturers create a sustainable documentation system that remains compliant throughout the device lifecycle.
 

👉 Download the full white paper below to discover how to structure MDR Technical Documentation in a clear, reliable and reviewer ready way.

Download the White Paper below

 

MockUp Resource Hub Web

View our other resources and company news

약물감시에서의 규정 준수 및 데이터 무결성 보장 QMS

제약 회사를 위한 글로벌 QMS 조화 추진

본 사례 연구는 Rephine이 글로벌 제약 ...
Read More
CSV CSV

규제 생명 과학 분야의 IT 품질 보증: 주요 통찰

IT 품질 보증은 규제된 생명 과학 분야에서 ...
Read More
약물감시에서의 규정 준수 및 데이터 무결성 보장 GxP 컨설팅

영국 제약 품질 시스템을 위한 실질적인 컴플라이언스 및 실사 준비

영국 제약 및 바이오테크 기업이 MHRA, E ...
Read More
BANNER EU MDR IVDR에 따른 시판 후 감시 PMS 실무 가이드 CSV

유럽의약품청(EMA)의 EU GMP 개정안 초안 실무 가이드

EU의 새로운 제품 책임 지침(2024/285 ...
Read More
BANNER EU MDR IVDR에 따른 시판 후 감시 PMS 실무 가이드 가이드

EU MDR/IVDR에 따른 시판 후 감시(PMS) 실무 가이드

EU의 새로운 제품 책임 지침(2024/285 ...
Read More
GMP 기준을 높이다 블로그 시리즈 헤더 이미지 5월 25일 GxP 컨설팅

제약 SOP를 위한 AI: 품질 관리 및 규정 준수 혁신

Rephine은 제약 및 바이오 기업이 Vee ...
Read More

CAPA 및 예외 관리 강화

Rephine의 맞춤형 GxP 교육이 제약 제 ...
Read More
GMP 기준을 높이다 블로그 시리즈 헤더 이미지 5월 25일 GMP 감사

EU GMP Annex 1 대 FDA 무균 가이드: 규정 준수 연계

EU 및 미국 규제 당국은 동일한 무균 보증 ...
Read More
GMP 기준을 높이다 블로그 시리즈 헤더 이미지 5월 25일 GMP 감사

GMP 및 GDP: 의약품 보관 및 운송에서 품질 확보

보관 및 운송은 단순한 물류가 아니라 중요한 ...
Read More
문의하기

귀사의 보증 여정을 강화하십시오

GMP 챕터 22: 하이브리드 문서화 표준에 적응하기